Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Inhibitors of HMG-CoA Reductase: Current and Future Prospects

Author(s): Narender Singh, Joaquin Tamariz, German Chamorro and Jose L. Medina-Franco

Volume 9, Issue 11, 2009

Page: [1272 - 1283] Pages: 12

DOI: 10.2174/138955709789878105

Price: $65

Abstract

High levels of cholesterol are a primary risk factor in the development of cardiovascular diseases. In this review, we have summarized the structural, chemical and computational aspects of hypocholesterolemic drugs, both statins and non-statins, that target enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA) to block cholesterol biosynthesis.

Keywords: 3-hydroxy-3-methylglutaryl-coenzyme A reductase, α-asarone, cardiovascular disease, low density lipoproteins, cholesterol, statins, side effects, structure-based drug design


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy